Latest Industry Insights

In efforts to find efficacious interventions against SARS-CoV-2, the novel coronavirus that causes COVID-19, hundreds of clinical trials have been designed and launched at an unprecedented rate across the globe. As data emerges from these studies there is an urgent need to track progress, to ensure transparent communication of findings, and to avoid duplication of efforts. Technology Networks spoke with Cytel’s Edward Mills, Vice President of Real-World Evidence and Senior Principal Scientist, to learn more about the global COVID-19 Trial Tracker the company has recently launched.

Technology Networks recently spoke with Nick Milne, co-founder and CSO at Octarine to learn more about what science says on the therapeutic benefits of psychedelic compounds, why a bio-based approach for manufacturing is advantageous and the challenges associated.

We recently spoke with experts at Bio-Rad to learn more about the reasons for, and significance of, false negative test results, and how the use of a more sensitive test could help to reduce this problem.

Diagnostic testing is playing a crucial role in global efforts to tackle the COVID-19 pandemic. By identifying infected individuals, efficient isolation and contact tracing can take place. However, what role could broader testing of COVID-19 patients have?

To try and make the process of applying for COVID-19 clinical trials easier, a free public health initiative called World Without COVID has been launched that will link users with all the trials they are eligible for.

London-based engineering startup Hadean, in collaboration with researchers at the Francis Crick Institute, hopes to use its simulation solution, the Aether Engine, to better model the spread of COVID-19 both between and within people. We spoke to Hadean’s Vice President of Operations, Mimi Keshani, to find out more.

Jagannath Swaminathan is the co-founder of Erisyon and a researcher at the Marcotte Lab at the University of Texas Austin. In this interview, we discuss the concept of next-generation protein sequencing, clinical proteomics and the critical role of protein sequencing in the fight against COVID-19.

Technology Networks spoke to Dr Christopher Stanley, CEO of MicrosensDx, to learn more about the RapiPREP® COVID-19 test and the difference point-of-care testing could make to the response to the pandemic.

In this interview we focus on Research-Aid Networks' activities in relation to the COVID-19 pandemic. Research-Aid Networks' Matthew Badham, highlights the importance of collaboration and communication in these unprecedented times, discusses what we currently know about the novel coronavirus (SARS-CoV-2) and elaborates on the analysis RAN has been conducting.

A consortium led by the Jenner Institute at Oxford University is working to rapidly develop, scale-up and manufacture the potential COVID-19 vaccine, ChAdOx1 nCov-19, or ChAdOx1, for fast-tracked clinical trials. Technology Networks spoke with Tony Hitchcock, Technical Director at Cobra Biologics to find out more about the consortium's aims, how the vaccine works and to gain insights on realistic timelines for vaccine development and manufacturing.